Your browser doesn't support javascript.
loading
Rapamycin Impairs Antitumor CD8+ T-cell Responses and Vaccine-Induced Tumor Eradication.
Chaoul, Nada; Fayolle, Catherine; Desrues, Belinda; Oberkampf, Marine; Tang, Alexandre; Ladant, Daniel; Leclerc, Claude.
Afiliação
  • Chaoul N; Institut Pasteur, Immune Regulation and Vaccinology Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. INSERM, U1041, Paris, France.
  • Fayolle C; Institut Pasteur, Immune Regulation and Vaccinology Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. INSERM, U1041, Paris, France.
  • Desrues B; Institut Pasteur, Immune Regulation and Vaccinology Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. INSERM, U1041, Paris, France.
  • Oberkampf M; Institut Pasteur, Immune Regulation and Vaccinology Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. INSERM, U1041, Paris, France.
  • Tang A; Institut Pasteur, Immune Regulation and Vaccinology Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. INSERM, U1041, Paris, France.
  • Ladant D; Institut Pasteur, Unité de Biochimie des Interactions Macromoléculaires, Paris, France. CNRS, Paris, France.
  • Leclerc C; Institut Pasteur, Immune Regulation and Vaccinology Unit, Equipe Labellisée Ligue Contre le Cancer, Paris, France. INSERM, U1041, Paris, France. claude.leclerc@pasteur.fr.
Cancer Res ; 75(16): 3279-91, 2015 Aug 15.
Article em En | MEDLINE | ID: mdl-26122844

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Vacinas Anticâncer / Sirolimo / Neoplasias Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Vacinas Anticâncer / Sirolimo / Neoplasias Idioma: En Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França